Material Event Form 8 K

On June 27, 2024, Applied DNA Sciences, Inc. (the "Company") received formal notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that, based on the information contained in the Company's Form 8-K, dated June 18, 2024, the Company complies with Nasdaq Listing Rule 5550(b)(1), which requires issuers listed on The Nasdaq Capital Market to maintain stockholders' equity of at least $2.5 million (the "Stockholders' Equity Requirement").

If, at the time of its next periodic report, the Company does not evidence compliance with the Stockholders' Equity Requirement, the Company may be subject to delisting. At that time, Nasdaq will provide written notification to the Company, which may then appeal Nasdaq's determination to a Hearings Panel.